the market?
Boston Scientific Corp.
NYSE: BSX
9.23
-0.02
(-0.22%)
| Today's Open | $9.27 |
|---|---|
| Previous Close | $9.25 |
| Daily Range | $9.18 - $9.39 |
| 52-Week Range | $4.79 - $9.39 |
| Market Cap | $12.5B |
| P/E Ratio | -2.86 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 31,314,801 |
| Average Daily Volume | 19,407,112 |
| Current FY EPS | $0.67 |
How do you think BSX
will perform against the market?
Top BSX Bull/Bear Pitches
BillZack (10.16)
Submitted
June 17, 2010
WAY OVERSOLD AND DUE FOR A GOOD RUN WITH PESSIMISM BEGINING TO ALEVIATE. GOOD PIPELINE OF PRODUCTS.
lickmyweinie (0)
Submitted
September 29, 2010
The simple truth is that competitors have superior products. The management can't dig themselves out of the hole their in. Damage form poor acquisitions and law suits have taken their toll. When ever … More
News & Commentary
What's Behind Medtronic's 5% Pop?
Fourth-quarter results impressed investors today.The 15 Most Overbought S&P 500 Stocks
With the S&P 500 Index notching its 16th record close of the year, it is not surprising that a number of stocks are overbought.1 Pioneering Device to Jump-Start the Cardiovascular Industry
Boston Scientific's atrial fibrillation device could be the key to this company's future growth.Will Obamacare Crush Medtronic's Earnings?
The medical-device maker reports earnings on Tuesday.Why This Big Buyback Isn't a Long-Term Solution
Edwards Lifesciences announces a $750 million repurchase plan, but is this move ignoring its real problems?Sector
Healthcare
Industry
Healthcare Information Services
Boston Scientific Corp. (BSX) Description
The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation. Website: http://www.bsci.com/
CEO Rating by Glassdoor
More details for Boston Scientific Jobs
Boston Scientific reviews from employees
